Because FAK and Src are important for determining focal adhesion dynamics, and, consequently, cancer cell proliferation, survival, and migration, they are the targets of some of the newer anticancer drugs (i.e., Dasatinib and Defactinib). The gene discussed is SRC; the disease is cancer.